A little Medication With That? |
"Overprescribed," by the way, was not among the terms NCADD used, nor did the Centers For Medicare And Medicaid Services (CMS.) The agency refers to prescription drug "over-utilization," and has proposed new protocols: "to protect Medicare beneficiaries and the Medicare Trust fund from the harm and damaging effects associated with prescription drug abuse." I would go much farther, and say, "use."
What fascinates me about addiction and obsessive behavior is that people would choose an altered state of consciousness that's toxic and ostensibly destroys most aspects of your normal life, because for a brief moment you feel okay. -Moby
In any case CMS wants Part D beneficiaries with "potential opioid or acetaminophen overuse, identified (presumably by medical providers.) Next would be to implement "appropriate controls" on these drugs for identified beneficiaries." -This seems to me punishing patients for using medications their physicians are eager to prescribe. It utterly circumvents the question of responsibility in marketing pharmaceuticals, both to medical professionals and the public.
The agency says it will employ data analysis to identify prescribers and pharmacies that may be engaged in fraudulent or abusive activities. Hmmmm, this would be a monumental task, considering how widespread the exploitive tactics are. CMS wants to use its data to guide its anti-fraud efforts, share results with Part D plan sponsors, law enforcement agencies, pharmacy and physician licensing boards, alluding to joint efforts to combat fraud and abuse.A key provision of the proposed rules would require Part D prescribers to enroll in Medicare. CMS believes this will ensure Part D drugs are prescribed only by qualified individuals ... fine, in theory. Additionally CMS seeks authority to revoke a physician's or eligible professional's Medicare enrollment if:
Approximately a year ago CMS implemented the OMS (Overutilization Monitoring System) to combat Part D fraud and abuse. The agency reports a substantial reduction in the number of acetaminophen and opioid overutilizers in Medicare Part D." We're waiting, but breathing all the while, for outcomes. Patient-oriented solutions ... that's another topic altogether.
What fascinates me about addiction and obsessive behavior is that people would choose an altered state of consciousness that's toxic and ostensibly destroys most aspects of your normal life, because for a brief moment you feel okay. -Moby
In any case CMS wants Part D beneficiaries with "potential opioid or acetaminophen overuse, identified (presumably by medical providers.) Next would be to implement "appropriate controls" on these drugs for identified beneficiaries." -This seems to me punishing patients for using medications their physicians are eager to prescribe. It utterly circumvents the question of responsibility in marketing pharmaceuticals, both to medical professionals and the public.
The agency says it will employ data analysis to identify prescribers and pharmacies that may be engaged in fraudulent or abusive activities. Hmmmm, this would be a monumental task, considering how widespread the exploitive tactics are. CMS wants to use its data to guide its anti-fraud efforts, share results with Part D plan sponsors, law enforcement agencies, pharmacy and physician licensing boards, alluding to joint efforts to combat fraud and abuse.A key provision of the proposed rules would require Part D prescribers to enroll in Medicare. CMS believes this will ensure Part D drugs are prescribed only by qualified individuals ... fine, in theory. Additionally CMS seeks authority to revoke a physician's or eligible professional's Medicare enrollment if:
- The agency determines he or she has a pattern of prescribing Part D drugs that is abusive (i.e., it represents a threat to the health and safety of Medicare beneficiaries or otherwise fails to meet Medicare requirements.)
- The DEA has revoked or suspended a physician's DEA Certificate of Registration.
- The licensing or administrative body for any state has curtailed a physician's or professional practice's ability to prescribe drugs.
Approximately a year ago CMS implemented the OMS (Overutilization Monitoring System) to combat Part D fraud and abuse. The agency reports a substantial reduction in the number of acetaminophen and opioid overutilizers in Medicare Part D." We're waiting, but breathing all the while, for outcomes. Patient-oriented solutions ... that's another topic altogether.
There is some hope that less expensive rehabilitation is becoming available. A drug in the form of a patch shows promise -- it is a Naltrexone patch. Naltrexone is already in use to treat alcohol addiction. In pill or injectable form, and under a number of brand names, it acts to prevent recidivism. It is also, interestingly, an opiate receptor antagonist, in other words, an individual who uses opiates will not become euphoric. It helps people addicted to opiates rapidly detoxify.
Be mindful my friend, of accountability, as it relates to choice. Preventing a problem is so much better than solving a problem through the backdoor.
Be mindful my friend, of accountability, as it relates to choice. Preventing a problem is so much better than solving a problem through the backdoor.
No comments:
Post a Comment